US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 6.220
  • +0.340+5.78%
Close Sep 9 16:00 ET
  • 6.220
  • 0.0000.00%
Post 20:01 ET
123.05MMarket Cap-3034P/E (TTM)

INmune Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
-63.16%14K
-58.56%155K
-71.13%28K
-56.12%43K
187.50%46K
-76.69%38K
106.63%374K
-40.49%97K
600.00%98K
Operating revenue
--0
-63.16%14K
-58.56%155K
-71.13%28K
-56.12%43K
187.50%46K
-76.69%38K
106.63%374K
-40.49%97K
600.00%98K
Cost of revenue
Gross profit
Operating expense
52.78%9.87M
70.73%11.03M
13.57%29.9M
46.49%8.41M
13.66%8.57M
0.83%6.46M
-2.71%6.46M
-10.26%26.33M
-37.57%5.74M
-16.54%7.54M
Selling and administrative expenses
21.78%2.81M
0.43%2.34M
3.94%9.62M
3.05%2.4M
8.56%2.59M
4.24%2.31M
-0.17%2.33M
5.31%9.26M
9.60%2.33M
-5.29%2.38M
-General and administrative expense
21.78%2.81M
0.43%2.34M
3.94%9.62M
3.05%2.4M
8.56%2.59M
4.24%2.31M
-0.17%2.33M
5.31%9.26M
9.60%2.33M
-5.29%2.38M
Research and development costs
70.03%7.05M
110.33%8.69M
18.78%20.27M
76.16%6.01M
16.01%5.99M
-0.98%4.15M
-4.08%4.13M
-16.92%17.07M
-51.75%3.41M
-20.87%5.16M
Operating profit
-53.88%-9.87M
-71.52%-11.02M
-14.60%-29.74M
-48.51%-8.38M
-14.58%-8.53M
-0.36%-6.41M
0.85%-6.42M
10.98%-25.95M
37.52%-5.64M
17.49%-7.44M
Net non-operating interest income expense
Other net income (expense)
232.22%119K
92.92%-8K
80.19%-267K
84.82%-29K
87.59%-35K
80.00%-90K
73.41%-113K
-13.56%-1.35M
70.20%-191K
35.47%-282K
Other non- operating income (expenses)
232.22%119K
92.92%-8K
80.19%-267K
84.82%-29K
87.59%-35K
80.00%-90K
73.41%-113K
-13.56%-1.35M
70.20%-191K
35.47%-282K
Income before tax
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
Income tax
Net income
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
Net income continuous Operations
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
Minority interest income
Net income attributable to the parent company
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
18.32%-7.73M
Basic earnings per share
-38.89%-0.5
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
-11.63%-0.48
5.26%-0.36
7.69%-0.36
19.15%-1.52
41.82%-0.32
21.82%-0.43
Diluted earnings per share
-38.89%-0.5
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
-11.63%-0.48
5.26%-0.36
7.69%-0.36
19.15%-1.52
41.82%-0.32
21.82%-0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0-63.16%14K-58.56%155K-71.13%28K-56.12%43K187.50%46K-76.69%38K106.63%374K-40.49%97K600.00%98K
Operating revenue --0-63.16%14K-58.56%155K-71.13%28K-56.12%43K187.50%46K-76.69%38K106.63%374K-40.49%97K600.00%98K
Cost of revenue
Gross profit
Operating expense 52.78%9.87M70.73%11.03M13.57%29.9M46.49%8.41M13.66%8.57M0.83%6.46M-2.71%6.46M-10.26%26.33M-37.57%5.74M-16.54%7.54M
Selling and administrative expenses 21.78%2.81M0.43%2.34M3.94%9.62M3.05%2.4M8.56%2.59M4.24%2.31M-0.17%2.33M5.31%9.26M9.60%2.33M-5.29%2.38M
-General and administrative expense 21.78%2.81M0.43%2.34M3.94%9.62M3.05%2.4M8.56%2.59M4.24%2.31M-0.17%2.33M5.31%9.26M9.60%2.33M-5.29%2.38M
Research and development costs 70.03%7.05M110.33%8.69M18.78%20.27M76.16%6.01M16.01%5.99M-0.98%4.15M-4.08%4.13M-16.92%17.07M-51.75%3.41M-20.87%5.16M
Operating profit -53.88%-9.87M-71.52%-11.02M-14.60%-29.74M-48.51%-8.38M-14.58%-8.53M-0.36%-6.41M0.85%-6.42M10.98%-25.95M37.52%-5.64M17.49%-7.44M
Net non-operating interest income expense
Other net income (expense) 232.22%119K92.92%-8K80.19%-267K84.82%-29K87.59%-35K80.00%-90K73.41%-113K-13.56%-1.35M70.20%-191K35.47%-282K
Other non- operating income (expenses) 232.22%119K92.92%-8K80.19%-267K84.82%-29K87.59%-35K80.00%-90K73.41%-113K-13.56%-1.35M70.20%-191K35.47%-282K
Income before tax -49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M
Income tax
Net income -49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M
Net income continuous Operations -49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M
Minority interest income
Net income attributable to the parent company -49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M18.32%-7.73M
Basic earnings per share -38.89%-0.5-69.44%-0.61-9.87%-1.67-46.88%-0.47-11.63%-0.485.26%-0.367.69%-0.3619.15%-1.5241.82%-0.3221.82%-0.43
Diluted earnings per share -38.89%-0.5-69.44%-0.61-9.87%-1.67-46.88%-0.47-11.63%-0.485.26%-0.367.69%-0.3619.15%-1.5241.82%-0.3221.82%-0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg